ダウンロード数: 35
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
bloodadvances.2023010598.pdf | 1.3 MB | Adobe PDF | 見る/開く |
タイトル: | Cord blood transplantation for adult lymphoid neoplasms in Europe and Japan |
著者: | Watanabe, Mizuki Kanda, Junya Volt, Fernanda Ruggeri, Annalisa Suzuki, Ritsuro Rafii-Elayoubi, Hanadi Kimura, Fumihiko Cappelli, Barbara Kondo, Eisei Scigliuolo, Graziana Maria Takahashi, Satoshi Kenzey, Chantal Rivera Franco, Monica Magdalena Okamoto, Shinichiro Rocha, Vanderson Chevallier, Patrice Sanz, Jaime Furst, Sabine Cornelissen, Jan J. Milpied, Noël J Uchida, Naoyuki Sugio, Yasuhiro Kimura, Takafumi Ichinohe, Tatsuo Fukuda, Takahiro Mohty, Mohamad Peffault de Latour, Régis Atsuta, Yoshiko Gluckman, Eliane |
著者名の別形: | 渡邊, 瑞希 諫田, 淳也 鈴木, 律朗 木村, 文彦 近藤, 英生 高橋, 聡 岡本, 真一郎 内田, 直之 杉尾, 康浩 木村, 貴文 一戸, 辰夫 福田, 隆浩 熱田, 由子 |
キーワード: | Lymphoid Neoplasia Transplantation |
発行日: | 13-Feb-2024 |
出版者: | American Society of Hematology |
誌名: | Blood Advances |
巻: | 8 |
号: | 3 |
開始ページ: | 640 |
終了ページ: | 652 |
抄録: | With the aim of identifying the different characteristics and prognostic factors of cord blood transplantation (CBT) in adult patients with lymphoid neoplasms in Europe and Japan, we conducted a collaborative study between European and Japanese registries. Patients aged 18-75 years receiving their first CBT (Europe: single CBT, n=192; double CBT, n=304; Japan: single CBT, n=1150) in 2000-2017 were analyzed. The number of patients with Hodgkin's lymphoma was higher in Europe (26% vs 5%) while that with mature T/NK-cell neoplasms was higher in Japan (20% vs 35%). The Japanese cohort comprised more elderly patients (>=50) (59% vs 39%) with higher refined disease risk index (rDRI) (high-very high: 49% vs 14%). High-very high rDRI (vs. low rDRI) was associated with inferior OS in common (Europe: HR 1.87 p=0.001; Japan: HR 2.34, p<0.001) with higher progression/relapse risks (Europe: HR 2.04, p=0.007; Japan: HR 2.96, p<0.001). Total body irradiation (TBI)-containing conditioning regimens contributed to superior OS both in Europe (vs TBI-RIC, non TBI-RIC: HR 1.93, p<0.001; non TBI-MAC: HR 1.90, p=0.003) and in Japan (non TBI-RIC: HR 1.71, p<0.001; non TBI-MAC: HR 1.50, p=0.007). The impact of HLA mismatches (>=2) on OS differed (Europe: HR 1.52, p=0.007; Japan: HR 1.18, p=0.107). Despite the different patient-disease-transplant characteristics, poor survival of patients receiving CBT for lymphoid neoplasms, especially in those with high rDRI was observed in both registries. The different impact of HLA mismatches on survival in the two registries calls attention to the fundamental differences among these populations. TBI should be considered in conditioning regimens. |
記述: | リンパ腫に対する臍帯血移植の予後予測因 --日欧国際共同研究--. 京都大学プレスリリース. 2023-12-19. |
著作権等: | © 2024 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. |
URI: | http://hdl.handle.net/2433/286818 |
DOI(出版社版): | 10.1182/bloodadvances.2023010598 |
PubMed ID: | 38100431 |
関連リンク: | https://www.kyoto-u.ac.jp/ja/research-news/2023-12-19-0 |
出現コレクション: | 学術雑誌掲載論文等 |
このアイテムは次のライセンスが設定されています: クリエイティブ・コモンズ・ライセンス